In the 2016 WHO classification, H3.3 G34-mutant diffuse gliomas were not considered as a distinct tumor type and most cases are currently classified as IDH-wildtype glioblastomas.5 However, in future classifications, H3.3 G34-mutant diffuse gliomas will be individualized. The gene discussed is IDH1; the disease is neoplasm.